tlooto
Sign up
SCOPUS

Neuroprotection

John Wiley & Sons, China

Neuroprotection is an academic journal published by John Wiley & Sons (China). Identifiers: ISSN 2770-7296, eISSN 2770-730X. Indexed in SCOPUS. Metrics: CiteScore 1.3, SJR 0.488, SNIP 0.46. tlooto lists 140 papers from this journal.

CiteScore

1.30

Scopus citation metric

SJR

0.488

SCImago rank

SNIP

0.46

Source normalized impact

Percentage rank

-

JIF percentile rank

Journal profile

ISSN
2770-7296
eISSN
2770-730X
Abbreviation
-
Publisher
John Wiley & Sons
Country
China

Web of Science categories

No Web of Science category data available.

Scopus ASJC categories

2746 Surgery2801 Neuroscience (miscellaneous)2808 Neurology

Papers in this journal

Recent papers

  1. Rehabilitation paired with vagus nerve stimulation for motor function of chronic ischemic stroke patients in China: Study protocol of a multicenter randomized controlled trial (Repair Study)

    2026

  2. Cerebral in situ ischemic postconditioning: From bench to bedside and beyond

    2026

  3. Comment on “Vitamin E for intraventricular hemorrhage prevention in preterm neonates: A systematic review and meta‐analysis”

    2026

  4. Post‐recanalization administration of rapamycin improves functional outcome and reduces infarct size in a rat model of ischemic stroke

    2026

  5. New insights into disease‐modifying factors and clinical translation for central nervous system diseases

    2026

Most cited papers

  1. Glutamate and excitotoxicity in central nervous system disorders: ionotropic glutamate receptors as a target for neuroprotection

    2024 · 57 citations

  2. Mesenchymal stem cell‐derived exosomes: Shaping the next era of stroke treatment

    2023 · 25 citations

  3. The dual role of microglia in ischemic stroke and its modulation via extracellular vesicles and stem cells

    2024 · 21 citations

  4. Preserving cognitive function in patients with Alzheimer’s disease: The Alzheimer’s Disease Neuroprotection Research Initiative (ADNRI)

    2023 · 20 citations

  5. Targeting brain‐derived neurotrophic factor in the treatment of neurodegenerative diseases: A review

    2024 · 17 citations